Figure 3From: IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort studyComparison of four mediators’ expression with patient’s mortality. Among four mediators, IL-6 presented strongest correlation with 6-month mortality in HCC patients (Figure 3), *P < 0.05 defined as significant.Back to article page